U.S., Oct. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07894133) titled 'Gait Parameters in Breast Cancer Receiving Chemotherapy Patients' on Oct. 13.
Brief Summary: Breast cancer is considered the most common type of malignancies, it is the most frequently diagnosed representing around 2.3 million cases. Where, their chemotherapy may cause fatigue affecting the overall quality of patient's life. Gait and balance are fundamental for activities of daily living and maintaining functional independence.
Study Start Date: Oct. 01
Study Type: OBSERVATIONAL
Condition:
Breast Cancer
Chemotherapy
Biodex Gait Trainer
Gait Parameters
Intervention:
OTHER: Gait parameter assessment
A Biodex Gait Trainer 3 (BIO...